D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PRLD holding history
Prelude Therapeutics Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PRLD overviewAll 13F holders of PRLDFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −49,184−100.0% | Sold out | Holders |
| Q3 2023 | 49,184 | $152.0K | <0.1% | −6,654−11.9% | Reduced | Holders |
| Q2 2023 | 55,838 | $251.3K | <0.1% | +8,589+18.2% | Added | Holders |
| Q1 2023 | 47,249 | $269.3K | <0.1% | −20,756−30.5% | Reduced | Holders |
| Q4 2022 | 68,005 | $410.8K | <0.1% | −10,876−13.8% | Reduced | Holders |
| Q3 2022 | 78,881 | $521.0K | <0.1% | −36,986−31.9% | Reduced | Holders |
| Q2 2022 | 115,867 | $605.0K | <0.1% | +92,256+390.7% | Added | Holders |
| Q1 2022 | 23,611 | $163.0K | <0.1% | +23,611 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −12,546−100.0% | Sold out | Holders |
| Q1 2021 | 12,546 | $544.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.